as posted before IMO Mr. Wong was appointed to search for future funding for PRR. and for a better deal.
M Rogers has done a good job but now PRR needs him to be in Europe (I believe in Germany at Present) to oversee Trial11b preparation and Trials 11b in USA.
I am like other people are disappointed - nothing is heard on the 6 patients and where Phase11b is advancing. But we will hear pretty soon IMO.
Like antthing else PRR could have initial teething problem.
what ever the reason I am sure PRR will solve it.
In past 6 months PRR have recruited very good people for these trials.
The market just need to know what is happening IMO
more info on new director albert yue-ling wong, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |